Furthermore, in a study evaluating the prognostic significance of serum LDH as a function of BRAF mutation status, it was shown that elevated serum LDH levels are associated with poor outcomes in patients with metastatic melanoma in both BRAF mutant and BRAF wild-type cases [55]. Here, BRAF is linked to metastatic melanoma.